Plain-English translation of NCT07509775 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at how combining traditional Chinese medicine with standard Western medical treatment affects ankylosing spondylitis, a type of arthritis that primarily affects the spine. Researchers will follow about 210 people over two years, comparing those who receive traditional Chinese medicine alongside their regular care with those who receive only standard Western treatment. The study will measure changes in the spine using special imaging scores to see if the combined approach slows disease progression.
Ankylosing spondylitis can cause progressive stiffness and damage to the spine, and current treatments don't work the same way for everyone. This study wants to understand whether adding traditional Chinese medicine to standard care might help slow or reduce this progression in ways that standard treatment alone cannot.
You likely qualify if…
You likely don't qualify if…
Researchers will review your medical records from the past three years, then follow you for up to two years with regular visits to track your condition. During this time, some participants will receive traditional Chinese medicine (herbal treatments or other traditional therapies) for at least 60% of their follow-up period alongside their regular medical care, while others will continue with standard Western medicine alone. You'll have imaging tests and assessments done periodically to measure how your spine is changing over time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Sponsor
China-Japan Friendship Hospital
Collaborators
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Guangxi Ruikang Hospital
Enrollment target
~210 participants
Started
January 2026
Primary completion
December 2027
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yuanyuan Zou, Doctor
China-Japan Friendship Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.